Creighton University School of Medicine, Phoenix, Arizona, USA.
Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.
J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107292. doi: 10.1016/j.jstrokecerebrovasdis.2023.107292. Epub 2023 Aug 10.
Post-stroke depression is a depressive mood disorder that follows a cerebrovascular accident and is a burden on stroke patients. Its management is included in clinical practice guidelines focused on stroke, and the recommended treatment is selective serotonin reuptake inhibitors in conjunction with psychotherapy. Clinical practice guidelines are recommendations used to standardize best medical practice, but there is no current evaluation of guidelines containing post stroke depression recommendations. Thus, the objective is to appraise the selected guidelines manner of development and quality.
A systematic literature review across three databases and a manual google search was performed to collect guidelines that included recommendations on the management of post-stroke depression. 1236 guidelines were screened, and 27 were considered for inclusion. Considered guidelines were manually reviewed by the authors, and ultimately, 7 met inclusion criteria. The appraisal of guidelines for research and evaluation was used to evaluate these guidelines' recommendations around post-stroke depression.
Three guidelines met the threshold considered "High", with all of them having five or more quality domains eclipse the cutoff score of 70%. Across all guidelines, the highest scoring domains were "Scope and Purpose", "Clarity of Presentation", and "Editorial Independence" with scores of 76.98%, 73.81%, and 91.36% respectively. The lowest scoring domains were "Applicability", "Rigor of Development", and "Stakeholder Involvement" with respective scores of 58.73%, 54.02%, and 43.90%.
The domains "Applicability", "Rigor of Development," and "Stakeholder Involvement" were the lowest scoring domains. These specific domains represent areas in which future guidelines could be more developed.
中风后抑郁症是一种继脑血管意外之后出现的抑郁情绪障碍,给中风患者带来了负担。其管理被纳入专注于中风的临床实践指南,推荐的治疗方法是选择性 5-羟色胺再摄取抑制剂联合心理治疗。临床实践指南是用于规范最佳医疗实践的建议,但目前还没有对包含中风后抑郁建议的指南进行评估。因此,目的是评估选定指南的制定方式和质量。
通过三个数据库和手动谷歌搜索进行系统文献回顾,以收集包含中风后抑郁管理建议的指南。筛选了 1236 条指南,有 27 条被认为符合纳入标准。考虑中的指南由作者手动审查,最终有 7 条符合纳入标准。研究和评估指南用于评估这些指南对中风后抑郁的建议。
有 3 条指南符合“高”的标准,所有指南都有 5 个或更多质量领域的得分超过 70%的截止分数。在所有指南中,得分最高的领域是“范围和目的”、“表述清晰度”和“编辑独立性”,得分分别为 76.98%、73.81%和 91.36%。得分最低的领域是“适用性”、“制定严谨性”和“利益相关者参与度”,得分分别为 58.73%、54.02%和 43.90%。
“适用性”、“制定严谨性”和“利益相关者参与度”是得分最低的领域。这些特定领域代表了未来指南可以进一步发展的领域。